In ovarian cancer, the ablation of LATS1/2, the key kinases within Hippo/YAP signaling, constitutively activates YAP/TAZ which upregulates the expression of the gene encoding PD-L1. The gene discussed is YAP1; the disease is ovarian carcinoma.